National Centre for Epidemiology and Population Health,Australian National University,Canberra, Australian Capital Territory,Australia.
Infection Prevention and Control,Canberra Hospital and Health Services,Canberra, Australian Capital Territory,Australia.
Infect Control Hosp Epidemiol. 2019 May;40(5):551-558. doi: 10.1017/ice.2019.41. Epub 2019 Mar 14.
We investigated the risk factors and origins of the first known occurrence of VRE colonization in the neonatal intensive care unit (NICU) at the Canberra Hospital.
A retrospective case-control study.
A 21-bed neonatal intensive care unit (NICU) and a 15-bed special care nursey (SCN) in a tertiary-care adult and pediatric hospital in Australia.
All patients admitted to the NICU and SCN over the outbreak period: January-May 2017. Of these, 14 were colonized with vancomycin-resistant Enterococcus (VRE) and 77 were noncolonized.
Demographic and clinical variables of cases and controls were compared to evaluate potential risk factors for VRE colonization. Whole-genome sequencing of the VRE isolates was used to determine the origin of the outbreak strain.
Swift implementation of wide-ranging infection control measures brought the outbreak under control. Multivariate logistic regression revealed a strong association between early gestational age and VRE colonization (odds ratio [OR], 3.68; 95% confidence interval [CI], 1.94-7.00). Whole-genome sequencing showed the isolates to be highly clonal Enterococcus faecium ST1421 harboring a vanA gene and to be closely related to other ST1421 previously sequenced from the Canberra Hospital and the Australian Capital Territory.
The colonization of NICU patients was with a highly successful clone endemic to the Canberra Hospital likely introduced into the NICU environment from other wards, with subsequent cross-contamination spreading among the neonate patients. Use of routine surveillance screening may have identified colonization at an earlier stage and have now been implemented on a 6-monthly schedule.
我们调查了堪培拉医院新生儿重症监护病房(NICU)中首例万古霉素耐药肠球菌(VRE)定植的危险因素和来源。
回顾性病例对照研究。
澳大利亚一家成人和儿科三级护理医院的 21 张床位新生儿重症监护病房(NICU)和 15 张床位特殊护理婴儿室(SCN)。
暴发期间入住 NICU 和 SCN 的所有患者:2017 年 1 月至 5 月。其中,14 例定植了万古霉素耐药肠球菌(VRE),77 例未定植。
比较病例和对照组的人口统计学和临床变量,以评估 VRE 定植的潜在危险因素。对 VRE 分离株进行全基因组测序,以确定暴发菌株的来源。
迅速实施广泛的感染控制措施使疫情得到控制。多变量逻辑回归显示,早期胎龄与 VRE 定植之间存在很强的关联(优势比[OR],3.68;95%置信区间[CI],1.94-7.00)。全基因组测序显示,分离株为高度克隆性屎肠球菌 ST1421,携带 vanA 基因,与堪培拉医院和澳大利亚首都领地先前测序的其他 ST1421 密切相关。
NICU 患者的定植与堪培拉医院特有的高度成功克隆有关,该克隆可能是从其他病房引入 NICU 环境的,随后在新生儿患者中发生交叉污染。常规监测筛查的使用可能更早地发现了定植,现在已每 6 个月安排一次。